AU2001282910A1 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands - Google Patents

Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands

Info

Publication number
AU2001282910A1
AU2001282910A1 AU2001282910A AU8291001A AU2001282910A1 AU 2001282910 A1 AU2001282910 A1 AU 2001282910A1 AU 2001282910 A AU2001282910 A AU 2001282910A AU 8291001 A AU8291001 A AU 8291001A AU 2001282910 A1 AU2001282910 A1 AU 2001282910A1
Authority
AU
Australia
Prior art keywords
quinuclidine
nicotinic
disease
treatment
substituted heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282910A
Other languages
English (en)
Inventor
Alice L. Bodnar
Jeffrey W. Corbett
Vincent E. Groppi Jr.
Eric Jon Jacobsen
Jason K. Myers
David W. Piotrowski
Bruce N. Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001282910A1 publication Critical patent/AU2001282910A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2001282910A 2000-08-21 2001-08-17 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands Abandoned AU2001282910A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22665200P 2000-08-21 2000-08-21
US60226652 2000-08-21
US60/226,652 2000-08-21
US28483201P 2001-04-19 2001-04-19
US60/284,832 2001-04-19
US60284832 2001-04-19
PCT/US2001/022597 WO2002016355A2 (fr) 2000-08-21 2001-08-17 Fragments heteroaryle a substitution quinuclidine destines au traitement de maladies

Publications (1)

Publication Number Publication Date
AU2001282910A1 true AU2001282910A1 (en) 2002-03-04

Family

ID=26920741

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282910A Abandoned AU2001282910A1 (en) 2000-08-21 2001-08-17 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands

Country Status (5)

Country Link
EP (1) EP1311505A2 (fr)
JP (1) JP2004506734A (fr)
AU (1) AU2001282910A1 (fr)
PE (1) PE20020505A1 (fr)
WO (1) WO2002016355A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214686B2 (en) 1997-06-30 2007-05-08 Targacept, Inc. Pharmaceutical compositions and methods for effecting dopamine release
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
NZ533259A (en) 2001-12-14 2007-10-26 Targacept Inc Methods and compositions for treatment of central nervous system disorders
DE10211416A1 (de) * 2002-03-15 2003-09-25 Bayer Ag Essig- und Propionsäureamide
DE10211415A1 (de) * 2002-03-15 2003-09-25 Bayer Ag Bicyclische N-Biarylamide
DE10234424A1 (de) * 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe
WO2004052889A1 (fr) * 2002-12-06 2004-06-24 Pharmacia & Upjohn Company Llc Composes utilises comme ligands radioactifs pour diagnostiquer une maladie
PL378026A1 (pl) * 2003-01-22 2006-02-20 Pharmacia & Upjohn Company Llc Leczenie chorób z zastosowaniem pełnych agonistów receptora Ó-7 nACh
JP2007533641A (ja) 2003-10-15 2007-11-22 ターガセプト，インコーポレイテッド 疼痛緩和および中枢神経系障害治療のためのアザビシクロ化合物
SE0303075D0 (sv) * 2003-11-19 2003-11-19 Astrazeneca Ab 4-substituted imidazoles
SE0303076D0 (sv) * 2003-11-19 2003-11-19 Astrazeneca Ab 5-substituted imidazoles
US20070270458A1 (en) * 2003-12-22 2007-11-22 Glen Ernst Nicotinic Acetylcholine Receptor Ligands
MXPA06007024A (es) * 2003-12-22 2006-08-31 Astrazeneca Ab Ligandos del receptor nicotinico de acetilcolina.
EP1751150A2 (fr) 2004-05-19 2007-02-14 Neurosearch A/S Nouveaux derives aryle azabicycliques
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
BRPI0614874A2 (pt) 2005-08-22 2011-04-19 Targacept Inc diazatricicloalcanos substituìdos com heteroarila, métodos para sua preparação e uso dos mesmos
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
AU2008293542B9 (en) 2007-08-27 2014-08-07 Dart Neuroscience (Cayman) Ltd. Therapeutic isoxazole compounds
MX2010003375A (es) 2007-10-01 2010-05-17 Comentis Inc Derivados de 1h-indol-3-carboxilato de quinuclidin-4-ilmetilo como ligandos del receptor de acetilcolina alfa 7 nicotinico para el tratamiento de enfermedad de alzheimer.
WO2009098282A1 (fr) * 2008-02-06 2009-08-13 Novasaid Ab Dérivés de thiophène 2,5-disubstitués de faible poids moléculaire et leur utilisation en thérapie
PT2254598E (pt) 2008-02-13 2013-10-16 Targacept Inc Combinação de agonistas nicotínicos alfa 7 e antipsicóticos
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
MA34957B1 (fr) * 2011-02-23 2014-03-01 Lupin Ltd Derives heteroaryle a titre modulateurs des nachr alpha 7
ES2606043T3 (es) * 2011-07-05 2017-03-17 Lupin Limited Derivados de biarilo como moduladores de nAChR
JPWO2013161871A1 (ja) * 2012-04-25 2015-12-24 興和株式会社 Ｔｌｒ阻害作用を有するチオフェン誘導体
JPWO2014069554A1 (ja) * 2012-10-31 2016-09-08 東レ株式会社 キヌクリジンアミド誘導体及びその医薬用途
TW201617342A (zh) 2014-07-11 2016-05-16 阿法馬根公司 調節α７活性之啶類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
IT1228288B (it) * 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
JPH04247081A (ja) * 1991-02-01 1992-09-03 Takeda Chem Ind Ltd ５員複素環酸アミド類
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
JP2002500652A (ja) * 1997-05-30 2002-01-08 ニューロサーアチ・アクティーゼルスカブ スピロ−キヌクリジン誘導体、その製造方法及びその使用方法
SE9904176D0 (sv) * 1999-11-18 1999-11-18 Astra Ab New use
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
WO2002016355A2 (fr) 2002-02-28
EP1311505A2 (fr) 2003-05-21
PE20020505A1 (es) 2002-06-12
WO2002016355A3 (fr) 2002-07-18
JP2004506734A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2001282910A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
AU2001282874A1 (en) Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282875A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
HUP0203803A3 (en) Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
AU2002303283A1 (en) Methods for treating drug addiction
AU2002348503A1 (en) Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2002230531A1 (en) Use of fgf-19 for inhibiting angiogenesis
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2002235166A1 (en) Chromatographic processes for recovery of isosorbide
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
AU2001250866A1 (en) Treatment for benign positional vertigo
AU2002222604A1 (en) Process for preparing substance GM-95
AU1037901A (en) Process for the preparation of paroxetine
HK1042288A1 (zh) 6-[[(芳基和雜芳基)氧]甲基]-萘基-2-甲亞胺酸酰胺衍生物，其製備方法及其在治療方面的應用
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
HUP0303980A3 (en) Nicotinic acetylcholine receptor ligands, process for their preparation and pharmaceutical compositions containing them
AU2002228593A1 (en) Process for preparing alpha-(3-arylthio)-acetophenones
AU2002304849A1 (en) Nicotinic acetylcholine receptor ligands
HUP0101332A3 (en) Process for preparing substituted pyridines
AU2000243657A1 (en) Method of binding integrin for treatment of cancer
ZA200207740B (en) Process for preparing alkanesulfonyl pyridines.
AU2001284745A1 (en) Method for improving psyllium functionality by solid-state reaction(s)